Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/24 19:00 | 5/8/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Afeyan Noubar | MA | D | 9 | S | -14,596 | 108.12 | 0 | -135 | 11,798 | D | ||||||||||||||||
4/16/24 16:23 | 4/15/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Hoge Stephen | MA | O | P | 7 | S.d | -5,841 | 99.77 | 0 | -59 | 1,684 | D | |||||||||||||||
4/9/24 16:09 | 4/8/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Mock James M | MA | O | CFO | 2 | S.d | -133 | 98.41 | 0 | -1 | 5 | D | |||||||||||||||
3/11/24 09:05 | 3/8/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Klinger Shannon Thyme | MA | O | GC | 3 | S.d | -128 | 96.38 | 0 | -1 | 9 | D | |||||||||||||||
2/16/24 16:10 | 2/16/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Bancel Stephane | MA | DO | CEO | 1 | S | -2,342 | 88.88 | 0 | -26 | 0 | 21,075 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |